Approvals (EMEA, Total)
09-30-2008 |
11:09 hs.
The European health authorities have approved Novartis´ osteoporosis drug Aclasta – called Reclasta in the U.S. - for use in men, as well as broadening its use, the Swiss drugmaker announced.
08-15-2008 |
11:45 hs.
06-27-2008 |
13:03 hs.
06-27-2008 |
12:33 hs.
Market launch in Q3 2008
05-07-2008 |
09:37 hs.
Bayer Schering Pharma announced its new low-dose oral contraceptive YAZ has been approved in the E.U., and the company plans to launch it on the market by autumn 2008.
Neupro
04-25-2008 |
11:28 hs.
Belgian pharmaceutical group UCB SA announced it had won sooner than expected approval for its Neupro restless legs syndrome (RLS) drug by the Committee for Medicinal Products for Human Use (CHMP).
1
02-06-2008 |
12:51 hs.
1
